RESUMEN
Brucellosis in pregnant women is reported to be associated with obstetric complications (OCs), and adequate data for human brucellosis during pregnancy are largely lacking. We performed this multicenter retrospective cross-sectional study to evaluate the epidemiology, clinical course, treatment responses, and outcomes of brucellosis among pregnant women. The study period comprised a 14-year period from January 2002 to December 2015. All consecutive pregnant women diagnosed with brucellosis in 23 participating hospitals were included. Epidemiological, clinical, laboratory, therapeutic, and outcome data along with the assessment data of the neonate were collected using a standardized questionnaire. Data of 242 patients were analyzed. The OC rate was 14.0% (34/242) in the cohort. Of the 242 women, 219 (90.5%) delivered at term, 3 (1.2%) had preterm delivery, 15 (6.2%) aborted, and 5 (2.1%) had intrauterine fetal demise. Seventeen (7.0%) of the newborns were considered as low birth weight. Spontaneous abortion (6.1%) was the commonest complication. There were no maternal or neonatal deaths and pertinent sequelae or complications were not detected in the newborns. Splenomegaly (p = 0.019), nausea and/or vomiting (p < 0.001), vaginal bleeding (p < 0.001), anemia (blood hemoglobin < 11 g/dL; p < 0.001), high level of serum aspartate aminotransferase (> 41 IU/L; p = 0.025), oligohydramnios on ultrasonography (p = 0.0002), history of taking medication other than Brucella treatment during pregnancy (p = 0.027), and Brucella bacteremia (p = 0.029) were the significant factors associated with OCs. We recommend that pregnant women with OC or with fever should be investigated for brucellosis if they live in or have traveled to an endemic area.
Asunto(s)
Brucelosis/complicaciones , Brucelosis/epidemiología , Complicaciones Infecciosas del Embarazo/microbiología , Aborto Espontáneo/microbiología , Adolescente , Adulto , Bacteriemia/epidemiología , Brucella/efectos de los fármacos , Brucella/aislamiento & purificación , Estudios Transversales , Femenino , Fiebre/epidemiología , Fiebre/microbiología , Humanos , Recién Nacido , Persona de Mediana Edad , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Estudios Retrospectivos , Esplenomegalia/epidemiología , Esplenomegalia/microbiología , Turquía/epidemiología , Adulto JovenAsunto(s)
Anticuerpos Antivirales/inmunología , Hepatitis Viral Humana/diagnóstico , Insectos Vectores/virología , Fiebre por Flebótomos/diagnóstico , Phlebovirus/inmunología , Psychodidae/virología , Enfermedad Aguda , Adulto , Animales , Diagnóstico Diferencial , Femenino , Hepatitis Viral Humana/virología , Humanos , Fiebre por Flebótomos/virología , Phlebovirus/aislamiento & purificación , Transaminasas/metabolismo , TurquíaRESUMEN
BACKGROUND: CD14 is expressed principally by cells of monocyte/macrophage lineage and plays a pivotal role in the innate immunity to intracellular infections. Recent research findings have revealed an association between the CD14 gene promoter polymorphism and several major infectious diseases. OBJECTIVE: The aim of the present study was to investigate the association between the CD14-159C/T polymorphism and tuberculosis in a Turkish population. METHODS: For this purpose, 88 consecutive patients with tuberculosis (63 pulmonary, 25 extrapulmonary) and 116 control subjects were enrolled into a prospective study. We determined CD14-159 genotypes by polymerase chain reaction - restriction fragment length polymorphism analysis and also measured serum concentrations of soluble CD14 (sCD14) by using a quantitative sandwich enzyme immunoassay technique. RESULTS: There was no significant difference in terms of genotype distribution between patients with tuberculosis (CC 18.2%, CT 48.9%, TT 33.0%) and controls (CC 12.9%, CT 50.9%, TT 36.2%) or between patients with pulmonary and extrapulmonary tuberculosis. Serum levels of sCD14 were significantly increased in patients with active tuberculosis compared to those with inactive tuberculosis and healthy controls (p<0.001). However, levels of sCD14 were not associated with any genotypes of CD14-159. CONCLUSION: The genotyping findings of the present study do not support a role for the CD14-159C/T polymorphism in the development of tuberculosis, at least in the geographical region of central Anatolia. Significantly elevated serum sCD14 levels in patients with active disease reflect the importance of the mononuclear phagocytic system activation in tuberculosis.
Asunto(s)
Predisposición Genética a la Enfermedad , Receptores de Lipopolisacáridos/genética , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas , Tuberculosis/genética , Adolescente , Adulto , Anciano , Femenino , Genotipo , Humanos , Inmunoensayo , Receptores de Lipopolisacáridos/sangre , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Estudios Prospectivos , Tuberculosis/inmunología , Turquía , Adulto JovenRESUMEN
A multiple-locus variable-number tandem-repeat analysis (MLVA) was applied to investigate the epidemiological relationship and genetic diversity among 162 human Brucella isolates collected from all geographic regions of Turkey in an 8-year period (2001 to 2008). The isolates were genotyped by using an MLVA assay developed in Orsay, France (MLVA-16(Orsay)) including eight minisatellite (panel 1) and eight microsatellite (panel 2, subdivided into 2A and 2B) markers. Panels 1 and 2A distinguish 14 genotypes; two of these represented 85% of the strains. Panel 2B displayed a very high discriminatory power. Three loci from panel 2B had diversity index values higher than 0.74. MLVA-16(Orsay) yielded 105 genotypes; 73 were represented by a unique isolate, and 32 included two to eight isolates. The isolates from different patients within the same outbreak or from the same patient before first-line therapy and after relapse showed identical genotypes. A number of MLVA genotypes appeared to be partially restricted to some geographic areas and displayed no annual variation, possibly reflecting persistence of genotypes in certain areas for a time span of at least a decade. This study, representing the first molecular typing results of human Brucella isolates from Turkey, indicated that Turkish human Brucella melitensis isolates were most closely related to the neighboring countries' isolates included in the East Mediterranean group.
Asunto(s)
Brucella/clasificación , Brucella/genética , Brucelosis/microbiología , Repeticiones de Minisatélite , Tipificación Molecular , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Brucella/aislamiento & purificación , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Epidemiología Molecular , Turquía , Adulto JovenRESUMEN
INTRODUCTION: Disseminated tuberculosis can involve several organs and clinically present with a potpourri of signs and symptoms. Early diagnosis and timely initiation of proper treatment are of great importance in preventing the later complications of the disease. CASE PRESENTATION: We report a case with disseminated tuberculosis who exhibited a wide spectrum of extrapulmonary involvement. The present case had lung and lymph node tuberculosis with abscess formation and remained undiagnosed for two years. Thereafter, multiple splenic abscesses developed that necessitated splenectomy, and at the final stage, he presented with scrotal abscesses. CONCLUSION: This paper highlights the diverse clinical appearances of disseminated tuberculosis and the significant importance of early diagnosis and treatment.
RESUMEN
Human brucellosis is a multisystemic infectious disease with a broad spectrum of clinical manifestations. Severe complications involving musculoskeletal, nervous, genitourinary, and cardiovascular systems may be encountered during the course of the disease; however, cutaneous complications have been reported rarely. We report a patient with brucellosis in whom the main presenting clinical feature was a maculopapular rash and fever. He was initially diagnosed as brucellosis based on the standard tube agglutination test and blood culture positivity. Histopathologic examination of these maculopapular lesions showed perivascular and periadnexal inflammation with loose granuloma formation including giant cells. We emphasize that brucellosis is an infectious disease that should always be kept in mind in the differential diagnosis of a patient with rash and fever, especially in endemic areas.
Asunto(s)
Brucelosis/complicaciones , Brucelosis/patología , Exantema/microbiología , Exantema/patología , Pruebas de Aglutinación , Antibacterianos/efectos adversos , Antihipertensivos/uso terapéutico , Brucelosis/tratamiento farmacológico , Diagnóstico Diferencial , Doxiciclina/efectos adversos , Quimioterapia Combinada , Úlcera Duodenal/inducido químicamente , Exantema/tratamiento farmacológico , Humanos , Hipertensión/tratamiento farmacológico , Linfoma Cutáneo de Células T/patología , Masculino , Persona de Mediana Edad , Rifampin/uso terapéutico , Neoplasias Cutáneas/patologíaRESUMEN
BACKGROUND: A number of studies have implicated an association between H. pylori and diverse extra-gastroduodenal pathologies. Chronic inflammation and increased immune response have been observed in bronchiectasis, likely gastroduodenal inflammatory diseases. H. pylori has been found in the trachea-bronchial aspirates of mechanically ventilated patients. Furthermore, the seroprevalence of H. pylori was found to be significantly higher in patients with bronchiectasis than in the control group. The present study was performed to investigate the possible role of H. pylori in the pathogenesis of bronchiectasis. METHODS: Prospectively, bronchoalveolar lavage fluid (BALF) was obtained from patients with bronchiectasis (n=26) and control (n=20). BALF was subjected to polymerase chain reaction (PCR) to determine the presence of H. pylori and serum IgG against H. pylori was determined with micro-ELISA kit. In addition, PCR was performed to determine H. pylori in surgically removed lung tissues from patients with bronchiectasis (n=97). RESULTS: H. pylori DNA was not detected in the BALF or in lung tissue samples. In addition, anti-H. pylori IgG level in patients with bronchiectasis did not show statistically significant difference from that of the control. CONCLUSIONS: Our study provided evidence that there might be no direct association between H. pylori and bronchiectasis; however, the indirect role of soluble products of H. pylori could not be excluded.
Asunto(s)
Bronquiectasia/microbiología , Líquido del Lavado Bronquioalveolar/microbiología , Helicobacter pylori/genética , Pulmón/microbiología , Adulto , Femenino , Infecciones por Helicobacter , Helicobacter pylori/metabolismo , Humanos , Pulmón/patología , Masculino , Persona de Mediana Edad , Reacción en Cadena de la PolimerasaAsunto(s)
Fascioliasis/diagnóstico , Anciano , Albendazol/uso terapéutico , Animales , Antiplatelmínticos/uso terapéutico , Fasciola hepatica/aislamiento & purificación , Fascioliasis/complicaciones , Fascioliasis/tratamiento farmacológico , Fascioliasis/parasitología , Humanos , Ictericia Obstructiva/etiología , Masculino , Prurito/etiologíaAsunto(s)
Vacuna contra Difteria, Tétanos y Tos Ferina/efectos adversos , Enfermedades Cutáneas Vasculares/etiología , Vacunación/efectos adversos , Anestésicos Locales/uso terapéutico , Difteria/prevención & control , Femenino , Humanos , Lactante , Lidocaína/uso terapéutico , Combinación Lidocaína y Prilocaína , Pomadas , Prilocaína/uso terapéutico , Enfermedades Cutáneas Vasculares/patología , Esteroides/administración & dosificación , Esteroides/uso terapéutico , Tétanos/prevención & control , Tos Ferina/prevención & controlRESUMEN
Anti neutrophil cytoplasmic antibody (ANCA) is strongly associated with some vasculitic disorders. Behçet's disease (BD) is a systemic vasculitis of unknown etiology. In this study, ANCA was found to be positive in 8 out of 66 patients (10.2%) with BD by combination testing consisting of immunofluorescence and ELISA [one patient showed an atypical pattern by indirect immunofloresence techique, 6 patients were reactive to bacterial-permeability increasing protein (BPI) and one patient was reactive to Cathepsin G in ELISA]. There were no vascular manifestations such as veneous or arterial thrombosis and arterial aneurysms in ANCA-positive patients with BD. The results suggest that ANCA may be found in a minority of BD as those in previous published studies.
RESUMEN
BACKGROUND AND AIM: Hepatitis B virus infection is an important public health problem in Turkey. Although hepatitis B vaccination is regarded as safe and effective for the general population, recommendations for hepatitis B immunization in patients with Behcet's disease are not clear. The aim of the present study was to elucidate the response of patients with Behcet's disease to hepatitis B vaccination and to determine whether hepatitis B vaccination has any adverse effects on the course of the disease. METHODS: Thirteen patients with Behcet's disease and 15 healthy individuals were enrolled into a prospective study. All subjects received the 3-dose series of routine hepatitis B vaccine. Anti-hepatitis B surface response was evaluated 1-3 months after the third dose of vaccine. RESULTS: The responder rates for patient and control groups were 12/13 (92.8%) and 14/15 (93.8%), respectively. Statistical analysis showed no significant difference between the two groups in terms of both the responder rates and mean antibody titers. CONCLUSIONS: These preliminary findings might suggest that the majority of patients with Behcet's disease develop protective antibody response after hepatitis B vaccination and that the immune response against hepatitis B surface antigen is adequate, efficient and intact.
Asunto(s)
Síndrome de Behçet/inmunología , Anticuerpos contra la Hepatitis B/sangre , Hepatitis B/prevención & control , Vacunación/efectos adversos , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Antígenos de Superficie de la Hepatitis B/inmunología , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del TratamientoRESUMEN
Activation of macrophages represents one of the initial events in innate immunity to intracellular infections. CD14 is expressed principally by cells of monocyte/macrophage lineage and plays a pivotal role in innate recognition of bacterial cell wall components, particularly lipopolysaccharides. We measured serum concentrations of soluble CD14 (sCD14) in serum samples obtained from 37 patients with brucellosis and 36 healthy controls. Serum levels of sCD14 were significantly increased in patients with brucellosis compared with those in healthy controls (P < 0.001). Re-analysis of serum samples after treatment in 25 patients demonstrated that treatment did not result in any significant decline in sCD14 levels. Despite a limited study population, these findings may implicate CD14 signaling as an important component of the initial anti-brucellar host response and suggest that activation of mononuclear phagocytic system is sustained even following effective treatment.
Asunto(s)
Brucelosis/sangre , Receptores de Lipopolisacáridos/sangre , Adolescente , Adulto , Antibacterianos/uso terapéutico , Biomarcadores/sangre , Sedimentación Sanguínea , Brucelosis/tratamiento farmacológico , Proteína C-Reactiva , Femenino , Humanos , Masculino , Persona de Mediana Edad , Receptores de Interleucina-2RESUMEN
Brucellosis is a systemic infectious disease with a broad spectrum of clinical manifestations. Arthritis is frequently observed in its course and may be one of the main presenting clinical features of the disease. We report a case of brucellar monoarthritis of the knee with a prolonged clinical course despite efficient antibiotic treatment.
Asunto(s)
Artritis Infecciosa/patología , Brucelosis/patología , Antibacterianos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Artritis Infecciosa/tratamiento farmacológico , Artritis Infecciosa/etiología , Brucella melitensis/aislamiento & purificación , Brucelosis/complicaciones , Brucelosis/tratamiento farmacológico , Doxiciclina/uso terapéutico , Quimioterapia Combinada , Humanos , Indometacina/uso terapéutico , Masculino , Persona de Mediana Edad , Rifampin/uso terapéutico , Estreptomicina/uso terapéutico , Sulfametoxazol/uso terapéutico , Resultado del Tratamiento , Trimetoprim/uso terapéuticoRESUMEN
Serum levels of proinflammatory cytokines, interleukin-1 beta (IL-1beta), tumor necrosis factor alpha, (TNF-alpha), and their inhibitors, IL-1 receptor antagonist (IL-1ra) and soluble TNF receptor 1 (sTNFR1), were determined by enzyme-linked immunosorbent assay in 104 patients with Behçet's disease (65 active, 39 inactive) and 40 healthy controls. The levels of IL-1beta and IL-1ra were significantly higher in both active and inactive patients than in control subjects (P<0.01 and P< 0.01, respectively). The concentrations of TNF-alpha and sTNFR1 were found to be higher in active patients than in controls (P< 0.01 and P< 0.001, respectively). There were no significant differences in the serum levels of these cytokines and their inhibitors between active and inactive patients. Significant increases in mean C-reactive protein level and erythrocyte sedimentation rate were found in patients with active vs inactive disease (P< 0.001 and P< 0.05, respectively). C-reactive protein values correlated with erythrocyte sedimentation rate but not with cytokines or their inhibitors. Our conclusion is that elevated serum TNF-alpha and sTNFR1 seem to be important inflammatory mediators in Behcet's disease. The statistically significant increase in these levels may arise from the severity of inflammation in the tissue or organ involved.
Asunto(s)
Síndrome de Behçet/inmunología , Receptores Tipo I de Factores de Necrosis Tumoral/sangre , Sialoglicoproteínas/sangre , Adolescente , Adulto , Síndrome de Behçet/metabolismo , Síndrome de Behçet/patología , Sedimentación Sanguínea , Proteína C-Reactiva/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Proteína Antagonista del Receptor de Interleucina 1 , Interleucina-1/sangre , Masculino , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Behçet's disease is a chronic vasculitis of unknown aetiology. Particular viral and bacterial pathogens have long been suspected of playing a role in the pathogenesis of the disease. Chlamydia pneumoniae is an intracellular bacterium capable of causing chronic infections. Some reports have suggested that the microorganism might be involved in the pathogenesis of vasculitis. The purpose of the present study was to investigate a possible correlation between C. pneumoniae infection and Behçet's disease. For this purpose, 90 consecutive patients with Behçet's disease and 50 healthy controls were enrolled. Immunoglobulin A (IgA) and IgG antibodies to C. pneumoniae were determined by 2 different techniques, namely indirect fluorescent antibody assay (IFA) and enzyme linked immunosorbent assay (ELISA). IgA antibodies to C. pneumoniae were detected in 17 (18.9%) patients with Behçet's disease and in 1 (2%) healthy control by IFA. By ELISA 27 patients (30.0%) and 6 controls (12.0%) had C. pneumoniae IgA. A significant difference was observed for IgA seropositivity between the 2 groups. Although IgG seropositivity between the 2 groups did not differ significantly, the number of individuals with IgG titres of > or = 1:1000 was significantly higher in the patient group (43.1%) compared with the control group (13.9%). These finding provide serological evidence of chronic C. pneumoniae infection in association with Behçet's disease.
Asunto(s)
Síndrome de Behçet/etiología , Infecciones por Chlamydophila/complicaciones , Chlamydophila pneumoniae/inmunología , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Adolescente , Adulto , Anticuerpos Antibacterianos/sangre , Enfermedad Crónica , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Recent reports have demonstrated that automated continous monitoring blood culture systems are fast and efficent in the detection of Brucella spp. In this retrospective study, the detection of these slow-growing bacteria by BACTEC 9050 blood culture system was evaluated. For this purpose, 60 patients, whose blood cultures were monitored by using BACTEC 9050 system were included into the study. Brucella spp. were isolated in 26 of 31 patients from whom two blood cultures were obtained and in 17 of 29 patients from whom single blood culture were obtained. The majority of isolates (84.1%) were detected within 7 days of incubation while the earliest detection was on the 3rd day in two samples. However, the bacteria were isolated by subcultures after 30 days of incubation in 8 of the samples. In conclusion, the routine 5 or 7 days-incubation protocols with BACTEC 9050 system were not efficient for the isolation of Brucella spp. Obtaining two blood cultures and prolonged incubation followed by subcultures increased the probability of bacterial isolation.
Asunto(s)
Bacteriemia/microbiología , Brucella/aislamiento & purificación , Brucelosis/microbiología , Adolescente , Adulto , Anciano , Bacteriemia/diagnóstico , Brucella/crecimiento & desarrollo , Brucelosis/diagnóstico , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de TiempoRESUMEN
Anti-tetanus antibody status was evaluated by enzyme-linked immunosorbent assay in 82 patients with Behçet's disease and 79 healthy individuals. 76 patients with Behçet's disease (92.7%) and 74 healthy controls (93.7%) had protective antibody titres against tetanus, with geometric mean levels of 1.0194 +/- 1.2755 and 1.3899 +/- 1.6533 IU/ml, respectively. The difference between the 2 groups was not statistically significant. There was a significant inverse correlation between antitoxin titres and age in patient and control groups. These findings imply that patients with Behçet's disease have intact overall immunity against tetanus.
Asunto(s)
Síndrome de Behçet/inmunología , Antitoxina Tetánica/inmunología , Tétanos/prevención & control , Adolescente , Adulto , Síndrome de Behçet/diagnóstico , Estudios de Casos y Controles , Estudios de Cohortes , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Persona de Mediana Edad , Probabilidad , Valores de Referencia , Sensibilidad y Especificidad , Estudios SeroepidemiológicosRESUMEN
The plasma levels of thrombomodulin in 54 patients with Behçet's disease (BD) and 20 healthy control subjects were studied. The mean thrombomodulin (TM) level was significantly higher in active BD patients than in inactive patients and healthy controls ( P<0.001 and <0.01, respectively). Plasma TM levels did not show a significant relation with clinical manifestations. Increased plasma TM levels are associated with active disease and may reflect the presence of endothelial cell activation and/or injury.